Feb. 5 at 4:54 PM
Nexalin Technology Inc announced the launch of NeuroCare, an AI-powered virtual clinic platform developed in collaboration with the University of California, San Diego. The platform marks the first phase of Nexalin’s digital health ecosystem, aiming to expand patient access, reduce costs, and enable long-term care for brain health conditions. NeuroCare integrates with Nexalin’s HALO Gen-3 headset, which delivers the company’s Deep Intracranial Frequency Stimulation (DIFS) technology.
Through the platform, patients with conditions such as Alzheimer’s, dementia, depression, anxiety, traumatic brain injury, and PTSD can receive at-home neurostimulation therapy with remote monitoring under a subscription-based model. Nexalin said the system removes traditional barriers to mental health treatment by enabling private, home-based care while allowing clinicians to manage therapy in real time.
$NXL